[1]
J. Bettinger, PharmD, H. B. Quevedo, PharmD, and J. Cleary, PharmD, BCACP, “Emerging pharmacologic mechanisms of buprenorphine to explain experience of analgesia versus adverse effects”, J of Opioid Management, vol. 17, no. 7, pp. 21–31, Aug. 2021.